Skip to content

Navigation Menu

Sign in
Sign up
#

biologics

Here are 16 public repositories matching this topic...

Moving past the old scarcity matrix into a unified, sovereign, multi-planetary network. This 6-module master manual bridges advanced data synthesis, psychological grounding protocols, and exopolitical theory. Formatted both as a high-fidelity guide for humans and a RAG-ready text framework for AI translation. Let's look up. ✨🛸

  • Updated Jun 23, 2026

Ruma Care — independent third-party profile of a public API surface, by API Evangelist. Ruma Care is a healthcare software company that streamlines the prior authorization process for biologic and infusion medications in infusion clinics. Its AI-powered platform pulls patient and insurance data from electronic health records (EHRs) to identify paye

  • Updated Sep 4, 2026

Visterra — independent third-party profile of a public API surface, by API Evangelist. Visterra is a Waltham, Massachusetts biologics research company developing antibody-based therapeutics for patients with immune-mediated and other difficult-to-treat diseases. It combines computational design, artificial intelligence, and experimental research wi

  • Updated Sep 4, 2026

Enlaza Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Enlaza Therapeutics is a clinical-stage biopharmaceutical company in La Jolla, California developing first-in-class covalent protein biologics for cancer and other serious diseases. Its proprietary War-Lock technology uses engineered unnatural amino ac

  • Updated Sep 4, 2026

Isomorphic Labs — independent third-party profile of a public API surface, by API Evangelist. Isomorphic Labs is a London-based AI-first drug discovery company spun out of Google DeepMind in 2021 and operating as an Alphabet subsidiary. Founded and led by Sir Demis Hassabis, the company applies frontier AI — including derivatives of the Nobel-winni

  • Updated Sep 4, 2026

Asymchem — independent third-party profile of a public API surface, by API Evangelist. Asymchem (Asymchem Laboratories (Tianjin) Co., Ltd.) is a global contract development and manufacturing organization (CDMO) with more than 25 years of experience delivering integrated, cGMP-compliant services across the pharmaceutical value chain.

  • Updated Sep 4, 2026

Schrödinger — independent third-party profile of a public API surface, by API Evangelist. Schrödinger is a New York-headquartered (NASDAQ: SDGR) computational science company that develops a physics-based and AI-driven molecular simulation platform used across drug discovery and materials science.

  • Updated Sep 4, 2026

Innovent — independent third-party profile of a public API surface, by API Evangelist. Innovent Biologics (信达生物制药) is a biopharmaceutical company founded in 2011 and headquartered in the Suzhou Industrial Park, China, that discovers, develops, manufactures, and commercializes high-quality biologic medicines for the treatment of oncology, autoimmune

  • Updated Sep 4, 2026

Elektrofi — independent third-party profile of a public API surface, by API Evangelist. Elektrofi is a Boston-based biopharmaceutical formulation technology company reinventing how biologic therapies are delivered to patients. Its Hypercon ultra-high-concentration microparticle platform and Elektroject process turn monoclonal antibodies, therapeuti

  • Updated Sep 4, 2026

Pearlbio — independent third-party profile of a public API surface, by API Evangelist. Pearl Bio is a synthetic biology company developing next-generation biomaterials for smart biologics. Its proprietary platform unites genome and ribosome engineering to produce novel biologics with diverse chemistries previously inaccessible, creating template-di

  • Updated Sep 4, 2026

Fable Therapeutics — independent third-party profile of a public API surface, by API Evangelist. Fable Therapeutics is a biopharmaceutical company developing protein-engineered biologics for obesity and metabolic disease. Its lead candidate, FBL-140, is an infrequently dosed monoclonal antibody antagonizing the activin receptor type II (ActR2) path

  • Updated Sep 4, 2026

Add this topic to your repo

To associate your repository with the biologics topic, visit your repo's landing page and select "manage topics."

Learn more

AltStyle によって変換されたページ (->オリジナル) /